Internal Reference Number: FOI_6282
Date Request Received: 06/09/2021 00:00:00
Date Request Replied To: 11/11/2021 00:00:00
This response was sent via: By Email
Request Summary: Biologic and biosimilar products within Rheumatology
Request Category: Companies
| Question Number 1: Could provide the numbers of patients treated by the rheumatology department (for any condition) in the last 3 months with the following drugs: • Abatacept [Orencia] • Adalimumab [Humira] • Adalimumab Biosimilars • Apremilast [Otezla] • Baricitinib [Olumiant] • Certolizumab [Cimzia] • Etanercept [Enbrel] • Etanercept Biosimilars • Filgotinib [Jyseleca] • Golimumab [Simponi] • Guselkumab [Tremfya] • Infliximab [Remicade] • Infliximab Biosimilars • Ixekizumab [Taltz] • Risankizumab [Skyrizi] • Rituximab [MabThera] • Rituximab Biosimilars • Sarilumab [Kevzara] • Secukinumab [Cosentyx] • Tocilizumab [Ro Actemra] • Tofacitinib [Xeljanz] • Upadacitinib [Rinvoq] • Ustekinumab [Stelara] | |
| Answer To Question 1: • Abatacept [Orencia] 42 • Adalimumab [Humira] 29 • Adalimumab Biosimilars 214 • Apremilast [Otezla] 5 • Baricitinib [Olumiant] 66 • Certolizumab [Cimzia] 39 • Etanercept [Enbrel] 10 • Etanercept Biosimilars 115 • Filgotinib [Jyseleca] 6 • Golimumab [Simponi] 23 • Guselkumab [Tremfya] 0 • Infliximab [Remicade] 9 • Infliximab Biosimilars 25 • Ixekizumab [Taltz] 24 • Risankizumab [Skyrizi] 0 • Rituximab [MabThera] 0 • Rituximab Biosimilars 19 • Sarilumab [Kevzara] 2 • Secukinumab [Cosentyx] 18 • Tocilizumab [Ro Actemra] 43 • Tofacitinib [Xeljanz] 31 • Upadacitinib [Rinvoq] 23 • Ustekinumab [Stelara] 7 | |
| To return to the list of all the FOI requests please click here |
Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
